Enterol 250

Brand History and Composition

Enterol is a well-known medicinal probiotic brand, primarily based on the yeast strain Saccharomyces boulardii CNCM I-745. It was originally discovered and developed in France following observations of the yeast's beneficial effects during a cholera outbreak in Indochina. Since its inception, the brand has become a global standard for the treatment and prevention of diarrhea associated with antibiotics, infections, or travel.

Manufacturing and Global Reach

The product is primarily manufactured in France, where the original research and isolation of the yeast strain took place. Production follows rigorous pharmaceutical standards to ensure the stability and viability of the probiotic microorganisms. Enterol is distributed globally through various local subsidiaries and partnerships, maintaining its reputation as a high-quality clinical-grade probiotic.

Ownership and Corporate Structure

The brand is owned by Biocodex, an independent multinational pharmaceutical company headquartered in Gentilly, France. Biocodex has grown from a specialized lab focused on gastroenterology into a diversified health group. The company remains the ultimate owner and primary manufacturer, managing the brand through its own network and local distributors across different continents.